Day: April 29, 2021

DUBLIN, Ireland, April 29, 2021 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate designed to treat excessive daytime sleepiness and cataplexy in patients with narcolepsy, announced today that it will host a conference call and live webcast at 8:30 a.m. ET on Monday, May 10, 2021, to provide a corporate update and discuss the Company’s financial results for the first quarter ended March 31, 2021. To access the conference call, investors are invited to dial (877) 407-9716 (U.S. and Canada) or (201) 493-6779 (International). The conference ID number is 13719428. A live audio webcast can be accessed by visiting the investor relations section of the Company’s website, www.avadel.com. A replay of the webcast will be...

SOUTH SAN FRANCISCO, Calif., April 29, 2021 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational conditionally activated antibody therapeutics based on its Probody® technology platform, today announced that it will report first quarter 2021 financial results on Thursday, May 6, 2021, after the close of U.S. markets. Following the announcement, the Company will host a conference call and webcast at 5:00 p.m. ET / 2:00 p.m. PT to discuss the results and provide a corporate update. Participants may access the live webcast of the conference call from the Events and Presentations page of CytomX’s website at www.cytomx.com. An archived replay of the webcast will be available on the Company’s website until May 13, 2021. Audio...

TORONTO, April 29, 2021 (GLOBE NEWSWIRE) — Worksport Ltd (OTC: WKSP) (or the “Company”) is excited to update its investors, shareholders, and supporters that it is in the final stages of negotiations for the leasing of their brand-new manufacturing facility. This major strategic manufacturing investment will provide the necessary infrastructure to support the Company’s growth while mass-producing its TerraVis™ tonneau cover systems & TerraVis COR™ battery systems, the former to be fully assembled in Canada. Once finalized, this move will facilitate unique, valuable opportunities that will afford Worksport’s business to grow into the space. One of the most important operational facets of the Company has always been to ensure scalability in Worksport’s manufacturing processes. This factory will not only support Worksport’s forthcoming...

CAMBRIDGE, Mass., April 29, 2021 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal imbalance, today announced the appointment of Merit Cudkowicz, M.D., to its board of directors. “We are thrilled to add Dr. Cudkowicz to the Praxis board of directors. As a world-renowned leader in neurology with a background in innovative, patient-guided clinical research, Dr. Cudkowicz will help drive us toward our goal of providing therapies to patients in need,” said Marcio Souza, president and chief executive officer of Praxis. Dr. Cudkowicz is the chief of neurology at Mass General Hospital, director of the Sean M. Healey & AMG Center for ALS, and...

ILUS 04-29ILUS – Autonomous Firefighting VehicleNEW YORK, April 29, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — ILUS International Inc is a Mergers and Acquisitions company focused on acquiring and developing technology-based companies globally. In addition to the 3 successful acquisitions already completed in 2021, Ilus has also entered into several Technology Partnerships, Joint Ventures and Memorandums of Understanding with companies whose innovative technology is disrupting their respective industries and which complements the Ilus strategy and vision. In line with this, one of Ilus’ acquisitions, FireBug, entered into a Memorandum of Understanding with Milanion Group in February 2021, for the purpose of developing an Autonomous Firefighting Vehicle based on the existing Milanion Agema Unmanned Ground...

VAN NUYS, Calif., April 29, 2021 (GLOBE NEWSWIRE) — Eco Innovation Group, Inc. (OTC:ECOX) (“ECOX” or the “Company”), an innovative company aggregating investments in new technologies that promote environmental and social well-being and the advancement of green energy solutions, is pleased to announce the release of a new video developed by the Company to help current and prospective investors better understand the mission and market positioning of Eco Innovation Group. View the new video Here. The video may also be found on the Company’s website at www.ecoig.com. Julia Otey-Raudes, President and CEO of Eco Innovation Group, commented, “This video is a very straightforward account of why this Company exists: we believe – not just in creating a more sustainable future for the planet and everyone and everything...

SAN DIEGO, April 29, 2021 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer, announced today that the Company will host a conference call and live audio webcast on Wednesday, May 5, 2021 at 5:00 p.m. ET to report its first quarter 2021 financial results and provide a corporate update. In order to participate in the conference call, please dial 800-708-4539 (toll free) or 847-619-6396 (toll) and refer to confirmation number 50156207. The live webcast can be accessed under “Events & Presentations” in the Investors section of the Company’s website at www.fatetherapeutics.com. The archived webcast will be available on the Company’s website...

SHENZHEN, China, April 29, 2021 (GLOBE NEWSWIRE) — Meten EdtechX Education Group Ltd. (Nasdaq: METX) (“Meten EdtechX” or the “Company”), one of the leading omnichannel English language training (“ELT”) service providers in China, today reported that the gross billing and student enrollment of its junior ELT business increased by 485% and 483% respectively in the first quarter of 2021 compared to the same period of last year. The figures confirm that the Company has returned to its pre-pandemic rapid growth trajectory. The Company is actively expanding its junior ELT business within its current network of 22 cities and has received positive market feedback. All of the Company’s learning centers achieved their profit goals in March, and the centers in 7 out of the 22 cities (Foshan, Guangzhou, Changsha, Dongguan, Chengdu, Shenzhen,...